$2.78 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 111 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | HORIZON PHARMA INCnote 5.000%11/1 | $82,435,000 | – | 31,760,461 | +100.0% | 2.96% | – | |
| NVRO | New | NEVRO CORP | $40,491,000 | – | 1,047,093 | +100.0% | 1.46% | – |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $35,774,000 | – | 2,920,300 | +100.0% | 1.28% | – |
| New | HEARTWARE INTL INCnote 3.500%12/1 | $21,778,000 | – | 20,464,000 | +100.0% | 0.78% | – | |
| CBST | New | CUBIST PHARMACEUTICALS INC | $21,157,000 | – | 210,200 | +100.0% | 0.76% | – |
| GILD | New | GILEAD SCIENCES INCput | $18,852,000 | – | 200,000 | +100.0% | 0.68% | – |
| JUNO | New | JUNO THERAPEUTICS INC | $18,703,000 | – | 358,149 | +100.0% | 0.67% | – |
| New | WEBMD HEALTH CORPnote 1.500%12/0 | $16,921,000 | – | 17,000,000 | +100.0% | 0.61% | – | |
| RMD | New | RESMED INC | $16,611,000 | – | 296,300 | +100.0% | 0.60% | – |
| ARAY | New | ACCURAY INC | $14,126,000 | – | 1,870,943 | +100.0% | 0.51% | – |
| PRTO | New | PROTEON THERAPEUTICS INC | $13,160,000 | – | 1,265,343 | +100.0% | 0.47% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $13,080,000 | – | 482,300 | +100.0% | 0.47% | – |
| New | ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0 | $12,795,000 | – | 13,000,000 | +100.0% | 0.46% | – | |
| HTWR | New | HEARTWARE INTL INC | $12,101,000 | – | 164,800 | +100.0% | 0.44% | – |
| New | FLUIDIGM CORP DELnote 2.750% 2/0 | $9,144,000 | – | 10,000,000 | +100.0% | 0.33% | – | |
| New | HEALTHWAYS INCnote 1.500% 7/0 | $7,828,000 | – | 6,700,000 | +100.0% | 0.28% | – | |
| CNXR | New | CONNECTURE INC | $7,206,000 | – | 799,750 | +100.0% | 0.26% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $5,578,000 | – | 464,083 | +100.0% | 0.20% | – |
| IMMU | New | IMMUNOMEDICS INCcall | $2,400,000 | – | 500,000 | +100.0% | 0.09% | – |
| DERM | New | DERMIRA INC | $2,106,000 | – | 116,267 | +100.0% | 0.08% | – |
| FLXN | New | FLEXION THERAPEUTICS INC | $2,016,000 | – | 99,847 | +100.0% | 0.07% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $1,274,000 | – | 10,000 | +100.0% | 0.05% | – |
| PTBI | New | PLASMATECH BIOPHARMACEUTICAL | $1,285,000 | – | 372,374 | +100.0% | 0.05% | – |
| ZTS | New | ZOETIS INCcl a | $1,080,000 | – | 25,097 | +100.0% | 0.04% | – |
| ILMN | New | ILLUMINA INC | $738,000 | – | 4,000 | +100.0% | 0.03% | – |
| MSTX | New | MAST THERAPEUTICS INC | $392,000 | – | 700,000 | +100.0% | 0.01% | – |
| PTBIW | New | PLASMATECH BIOPHARMACEUTICAL*w exp 10/24/201 | $300,000 | – | 375,000 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.